Skip to content

DR. MEUWIS B.

Active
Private limited companyfounded 2010active for 16 yearsHeerbaan 136, 3582 Beringen, BelgiumKBO/BCE: BE 0830.129.364
Summary

DR. MEUWIS B. has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €751,406 and a net result of €191,382. Equity has been growing by about 13% per year since 2018. Its solvency ranks better than 59% of 20,720 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 11-10-2010 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.193.082.007 3582 Beringen, since 11-10-2010
Financial year end
31 December
Peppol
Reachable since 27-10-2025

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€273,056
▲ 17.6%
Turnover
≈ €420,000
estimated
Profit
€191,382
▲ 19.2%
Equity
€751,406
▼ 12.0%
Total assets
€1.1m
▲ 21.6%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 3.16, cash €263,385Figures for financial year 2025 (filed on 13-06-2026)Size: total assets €1.1mShow the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 46% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 96-4
equity 71.2% of total assets
Liquidity 69-22
short-term debt 28.8% · cash 25.0%
Profitability 91-1
return on assets 18.1%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,173 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025highest value 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €65,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.16 (64.45 in 2024), above the usual 1.5. Short-term debt is 28.8% and cash 25% of total assets. 28.8% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 59% of them on solvency, 50% on liquidity, 48% on profitability and 25% on growth.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 3.16, cash €263,385
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 13-06-2026)
NBB · annual accounts
lowers risk · Size: total assets €1.1m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-06-2026, 51 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
51 days early
2024
45 days early
2023
on the day
2022
31 days late
2021
31 days late
2020
31 days late
2019
31 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 4 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 1 August (4 of the last 5 accounts filed within 46 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 89% of companies in human healthsector median €124,634 · 20,722 companies €751,406 View
  • Positive: 8 profitable years in a rowprofit 2025: €191,382 8 years View

Recent changes

  1. · Gazette deed Resignation: MEUWIS Bruno Jozef Maria (director)Reappointment: MEUWIS Bruno Jozef Maria (director)
  2. · Gazette deed Incorporation
All 16 events

Comparable companies

These companies have the same main activity as DR. MEUWIS B.: general medical practice (NACE 86210). They are comparable in size and age: total assets between €966,000 and €1.1m, founded between 2008 and 2010.

CompanyTotal assetsGross margin
DR. MEUWIS B. Beringen€1.1m€0.3m
Dokter Nele De keersmaecker Sint-Truiden€1.0m€0.3m
DR SOADE NOURI Nieuwerkerken (Limb.)€1.0m€0.3m
DR.BEN HÔREN Heusden-Zolder€1.0m€0.3m
DOKTER TRUI SPRUYTTE Kortemark€1.0m€0.3m
Dr. Planckaert Geert Merelbeke-Melle€1.1m€0.3m
Medicare Evere Evere€1.0m€0.3m
Full comparison

Key facts about DR. MEUWIS B.

What is the company number of DR. MEUWIS B.?
The company number of DR. MEUWIS B. is 0830.129.364. The VAT number is the same number with BE in front: BE 0830.129.364.
Where is DR. MEUWIS B. based?
The registered office is at Heerbaan 136, 3582 Beringen.Company details
What does DR. MEUWIS B. do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. MEUWIS B.?
The legal form of DR. MEUWIS B. is Private limited company (BV).
When was DR. MEUWIS B. founded?
DR. MEUWIS B. was founded on 11-10-2010.
Is DR. MEUWIS B. still active?
Yes, DR. MEUWIS B. is an active enterprise in the KBO register.
What is the turnover of DR. MEUWIS B.?
The turnover in financial year 2025 is ≈ €420,000. This figure is estimated from the gross margin of €273,056 and 36 comparable companies (NACE 862). It probably lies between €380,000 and €530,000.Financials
Is DR. MEUWIS B. profitable?
In financial year 2025, DR. MEUWIS B. made a profit of €191,382.
Where can I find the annual accounts of DR. MEUWIS B.?
DR. MEUWIS B. filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. MEUWIS B. due?
DR. MEUWIS B. must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.